Vimarsana
Biggest News Aggregation in the World

Treating Anemia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Treating Anemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Treating Anemia Today - Breaking & Trending Today

Iron deficiency in Coeliac disease and obesity - Vimarsana News

Iron deficiency in Coeliac disease and obesity

To be decided by the editor

NICE Recommends Astellas' EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease - Vimarsana News

NICE Recommends Astellas' EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease

NICE Recommends Astellas’ EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease EVRENZOTM (roxadustat) is the first hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to be recommended by NICE1Over 75,000 adults in England and Wales living with...

PHARMANUTRA: NEW SCIENTIFIC STUDIES ON SUCROSOMIAL® TECHNOLOGY APPLIED TO IRON - Vimarsana News

PHARMANUTRA: NEW SCIENTIFIC STUDIES ON SUCROSOMIAL® TECHNOLOGY APPLIED TO IRON

/PRNewswire/ -- Since 2003, the scientific research activity of PharmaNutra (MTA; Ticket PHN), a group of companies specialized in the development, production...

Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease - Vimarsana News

Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and FibroGen, Inc. (Nasdaq: FGEN, CEO: Enrique Conterno,...